En bloc resection of bladder tumour : the rebirth of past through reminiscence
Teoh, Jeremy Yuen-Chun (European Association of Urology-Young Academic Urologists (EAU-YAU))
D'Andrea, David (Medical University of Vienna)
Gallioli, Andrea (Institut d'Investigació Biomèdica Sant Pau)
Yanagisawa, T. (The Jikei University School of Medicine)
MacLennan, S. (University of Aberdeen)
Nicoletti, R. (Università degli Studi di Firenze)
Fai, N.C. (The Chinese University of Hong Kong)
Maffei, D. (Humanitas University)
Hurle, R. (Humanitas Research Hospital (Itàlia))
Lusuardi, L. (Paracelsus Medical University)
Malavaud, B. (Institut Universitaire du Cancer Toulouse-Oncopôle)
Miki, J. (The Jikei University School of Medicine)
Kramer, M. (Universitätsklinikum Schleswig-Holstein)
Mostafid, Hugh (Royal Surrey Hospital)
Enikeev, D. (Sechenov University)
Babjuk, Marek (Charles University)
Breda, Alberto (Institut d'Investigació Biomèdica Sant Pau)
Shariat, S. (Al-Ahliyya Amman University)
Gontero, Paolo (Università degli Studi di Torino (Torí, Itàlia))
Herrmann, T. (Kantonsspital Frauenfeld)
Universitat Autònoma de Barcelona

Date:	2023
Abstract:	To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer. In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT. Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38. 1 to 28. 5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting. ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Bladder cancer ; ERBT ; En bloc resection ; NMIBC ; TURBT ; Transurethral resection
Published in:	World journal of urology, Vol. 41 Núm. 10 (october 2023) , p. 2599-2606, ISSN 1433-8726

DOI: 10.1007/s00345-023-04547-0
PMID: 37584691

8 p, 1.2 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles